X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Chronic Myelogenous Leukemia Treatment Companies

This report lists the top Chronic Myelogenous Leukemia Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Chronic Myelogenous Leukemia Treatment industry.

Chronic Myelogenous Leukemia Treatment Top Companies

  1. Bristol-Myers Squibb Co

  2. Pfizer, Inc.

  3. Teva Pharmaceutical Industries Ltd.

  4. Takeda Pharmaceutical Co. Ltd

  5. Novartis AG

*Disclaimer: Top companies sorted in no particular order

 Chronic Myelogenous Leukemia Treatment Market Major Players

Chronic Myelogenous Leukemia Treatment Market Concentration

Chronic Myelogenous Leukemia Treatment Market Concentration

Chronic Myelogenous Leukemia Treatment Company List

                          • Bristol-Myers Squibb Co.

                          • Novartis AG

                          • Pfizer Inc.

                          • Takeda Pharmaceutical Company Limited

                          • Teva Pharmaceutical Industries Ltd.

                          • Viatris Inc. (Mylan)

                          • Merck & Co., Inc.

                          • F. Hoffmann-La Roche Ltd.

                          • Boehringer Ingelheim International GmbH

                          • Sanofi

                          • Cipla Inc. (Cipla USA Inc.)

                          • Amneal Pharmaceuticals LLC

                          • Accord Healthcare, Inc

                          • Fresenius Kabi AG


                      Specific to Chronic Myelogenous Leukemia Treatment Market
                      Need More Details On Market Players And Competitors?
                      Download Sample

                      Chronic Myelogenous Leukemia Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)